Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06GQO
|
||||
Former ID |
DNC004502
|
||||
Drug Name |
N-Butyl-N'-(4-methyl-benzoyl)-guanidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526204] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H19N3O
|
||||
Canonical SMILES |
CCCCN=C(N)NC(=O)C1=CC=C(C=C1)C
|
||||
InChI |
1S/C13H19N3O/c1-3-4-9-15-13(14)16-12(17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H3,14,15,16,17)
|
||||
InChIKey |
ALSYKIYWLYFZIK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel protein type 5 subunit alpha | Target Info | Inhibitor | [526204] | |
KEGG Pathway | Adrenergic signaling in cardiomyocytes | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.